摘要
目的观察尤瑞克林联合氯吡格雷治疗进展性脑梗死的疗效及安全性。方法进展性脑梗死患者56例随机分为观察组和对照组两组,在给予常规治疗同时,对照组28例给予口服氯吡格雷,观察组28例给予应用尤瑞克林联合氯吡格雷,均于治疗前后14d评价神经功能。结果观察组治疗14d后临床疗效评定总有效率96.43%,明显优于对照组75.00%。观察组神经功能缺损评分与对照组比较,差异也有统计学意义(P<0.05)。结论尤瑞克林联合氯吡格雷治疗进展性脑梗死疗效较好。
Objective To observe the curative effect and medical security of Urinary Kallidinogenase combined with Clopidogrel for progressive cerebral infarction. Methods 56 cases patient were divided into two groups randomly. Besides taking with conventional therapy, administer 28 cases in the comparison team with oral Clopidogrel, administer 28cases in the observation team with Urinary Kallidinogenase combined with Clopidogrel, evaluate the neurological functions of both teams in about 14days after treatment. Results The clinical efficiency of the observation team is 96.43%, which is obviously higher than the comparison team 75%. There is statistical significant （P 〈0.05 ） when compared with the comparison team on neurological deficiency. Conclusion It is satisfy of effects of Urinary Kallidinogenase combined with Clopidogrel for progressive cerebral infarction.
出处
《中国现代医生》
2011年第20期87-88,共2页
China Modern Doctor
关键词
尤瑞克林
氯吡格雷
进展性脑梗死
Urinary Kallidinogenase
Clopidogrel
Progressive cerebral infarction
